Pinnacle Family Advisors, LLC Abb Vie Inc. Transaction History

Pinnacle Family Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $9,544 - $10,991	66 Added 1.3%	5,131 $817,000
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $14,522 - $17,416	-105 Reduced 2.03%	5,065 $819,000
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $30,599 - $35,096	228 Added 4.61%	5,170 $694,000
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $233,403 - $296,732	1,696 Added 52.25%	4,942 $757,000
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $428,407 - $531,532	3,246 New	3,246 $526,000
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $194,014 - $229,563	-2,161 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $193,539 - $212,231	2,161	2,161 $209,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Pinnacle Family Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Pinnacle Family Advisors, LLC with notifications on news.